Table of Contents
Why Peptide Purity Testing Matters in Research
Peptide purity testing is not just a marketing detail when sourcing peptides for laboratory research; it is the foundation of reliable results. Proper peptide purity testing ensures that purity is not a vague claim — it is the single most important variable that determines whether your experimental results are meaningful. Impure peptides introduce confounding variables that can compromise data integrity, waste months of research effort, and lead to irreproducible findings.
A peptide with 85% purity, for example, means that 15% of the vial contents are something other than your target compound: truncated sequences, deletion peptides, oxidized variants, residual solvents, or synthesis byproducts. These contaminants can exhibit their own biological activity, interact unpredictably with your assay system, or produce cytotoxic effects that skew results.
Rigorous peptide purity testing is central to our quality promise. At Aminopeptides.ca, every lot ships with ≥99.9% HPLC purity and a third-party Certificate of Analysis. Here is what that means and why it matters for your research.
How Peptide Purity Testing Is Performed
High-Performance Liquid Chromatography (HPLC)
HPLC is the gold standard for peptide purity testing and assessment. The technique separates a peptide sample into its individual components by passing it through a chromatography column under high pressure. Each component interacts differently with the column’s stationary phase, causing it to elute (emerge) at a characteristic retention time.
The result is a chromatogram — a graph showing peaks that correspond to each component in the sample. The target peptide appears as the dominant peak, and purity is calculated as the area of that peak divided by the total area of all peaks, expressed as a percentage. A purity of ≥99.9% means the target peptide accounts for at least 99.9% of the total UV-absorbing material in the sample.
Reversed-Phase HPLC (RP-HPLC)
Most peptide purity testing uses reversed-phase HPLC, where the stationary phase is hydrophobic (typically C18-bonded silica) and the mobile phase is a gradient of water and acetonitrile with a small percentage of trifluoroacetic acid (TFA). This configuration excels at separating peptides from closely related impurities — including deletion sequences that differ by just one amino acid.
Mass Spectrometry (MS)
While HPLC tells you how pure a sample is, mass spectrometry tells you what is actually in it. Electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization (MALDI-MS) measures the molecular weight of the peptide with high accuracy. If the observed mass matches the calculated molecular weight of your target sequence, you have confirmation that the dominant HPLC peak is indeed your peptide — not a co-eluting contaminant of similar polarity.
Reputable suppliers provide both HPLC purity data and MS confirmation on their Certificates of Analysis.
Amino Acid Analysis (AAA)
Amino acid analysis provides a third layer of identity confirmation and is also the primary method for determining net peptide content. The peptide is hydrolyzed (typically in 6M HCl at 110°C for 24 hours), breaking it into individual amino acids that are then quantified via ion-exchange chromatography or HPLC. If the observed amino acid ratios match the expected ratios for the target sequence, identity is confirmed.
AAA has limitations: tryptophan and cysteine are partially or fully destroyed during acid hydrolysis, requiring alternative methods (alkaline hydrolysis for tryptophan, performic acid oxidation for cysteine) for peptides containing those residues. Despite these limitations, AAA remains the reference method for determining how much of a lyophilized powder is actually active peptide.
Endotoxin Testing (LAL Assay)
Endotoxin testing complements peptide purity testing by ensuring injectable-grade peptides are free of bacterial contamination.
For peptides intended for cell-culture or in-vivo research, endotoxin contamination is a critical concern. Bacterial endotoxins (lipopolysaccharides from Gram-negative bacteria) are potent immune activators that can confound any experiment involving living systems. The Limulus Amebocyte Lysate (LAL) assay detects endotoxin levels with high sensitivity.
Standard research-grade thresholds are typically <1 EU/μg of peptide. For injectable in-vivo research, regulatory guidelines (such as FDA standards for parenteral drugs) specify <5 EU/kg of body weight. Peptides intended for cell-culture work may require even lower endotoxin levels depending on the sensitivity of the cell line being used.
Net Peptide Content: The Number Most Researchers Overlook
One of the most misunderstood aspects of peptide quantification is the difference between gross weight and net peptide content (NPC). A vial labeled “5 mg” typically contains 5 mg of total lyophilized powder — but not all of that powder is active peptide.
Lyophilized peptides are typically 60–80% actual peptide by gross weight. The remainder consists of:
- Counterions (15–20%): During HPLC purification, peptides bind counterions — most commonly trifluoroacetate (TFA) from the mobile phase. These TFA salts add mass without adding active peptide. Some manufacturers offer acetate-salt forms, which have lower counterion mass per molecule.
- Residual water (5–8%): Even after lyophilization, trace moisture remains bound to the peptide.
- Residual salts: Buffer salts and other process residues contribute small amounts of non-peptide mass.
This means a “5 mg” vial at 70% NPC contains approximately 3.5 mg of active peptide. For research requiring precise molar concentrations, NPC must be accounted for. Reputable suppliers report NPC on their Certificate of Analysis or can provide it upon request.
Peptide Purity Testing Reports: Reading a Certificate of Analysis
A proper Certificate of Analysis should include the following data points, each serving a specific purpose:
| CoA Field | What It Tells You | What to Look For |
|---|---|---|
| Sequence | The amino acid sequence of the peptide | Matches your target compound exactly |
| Molecular weight (calculated) | Theoretical MW based on sequence | Should be stated to at least 2 decimal places |
| Molecular weight (observed) | MW measured by mass spectrometry | Should match calculated MW within ±1 Da |
| HPLC purity | Percentage of target peptide in the sample | ≥95% for research grade; ≥98% for in-vivo; ≥99% preferred |
| Net peptide content | Percentage of gross weight that is active peptide | Typically 60–80%; needed for precise concentration calculations |
| Appearance | Physical description of the product | White to off-white lyophilized powder (usually) |
| Lot/batch number | Traceability identifier | Must match the number on your vial label |
| Endotoxin level | LAL assay result | <1 EU/μg for research grade |
If a supplier cannot provide a lot-specific CoA upon request, that is a significant red flag. Generic or undated certificates should be treated with scepticism.
Common Peptide Impurities Found During Peptide Purity Testing
Truncated Sequences
During solid-phase peptide synthesis (SPPS), each amino acid coupling step has a yield of approximately 99% for well-optimized protocols. Over a 15-residue peptide like BPC-157, this means a small percentage of chains fail to incorporate one or more amino acids. These truncated (shorter) sequences are the most common impurity class and are typically removed during HPLC purification.
Deletion Peptides
A deletion peptide is missing one amino acid from the middle of the sequence (rather than being truncated at the end). These are more difficult to separate by HPLC because their polarity may be very similar to the target peptide. High-resolution RP-HPLC with optimized gradients is required to resolve deletion peptides from the target.
Oxidized Variants
Oxidized variants are a common concern in peptide purity testing, particularly for methionine- and cysteine-containing sequences.
Peptides containing methionine, cysteine, or tryptophan residues are susceptible to oxidation during synthesis, purification, or storage. Methionine oxidizes to methionine sulfoxide, while cysteine can form unintended disulfide bonds (disulfide scrambling). Oxidized variants may exhibit altered biological activity. Proper lyophilization, inert-gas headspace, and cold storage minimize oxidation risk.
Residual Solvents and Counterions
TFA from the HPLC purification process and residual acetonitrile or water can remain in the lyophilized product. High-quality manufacturers use extensive lyophilization cycles and may convert TFA salts to acetate salts for applications where TFA is problematic (such as cell-culture work, where TFA can affect cell viability at high concentrations).
Purity Grades: What the Numbers Mean
| Purity Grade | HPLC Purity | Typical Application |
|---|---|---|
| Crude | <70% | Preliminary screening, antibody production |
| Desalted | 70–85% | ELISA standards, basic binding assays |
| Standard research | ≥95% | Most in-vitro assays and cell-culture work |
| High purity | ≥98% | Quantitative assays, in-vivo studies, SAR studies |
| Ultra-high purity | ≥99% | Clinical-grade reference standards, pharmacokinetic studies |
Aminopeptides.ca peptides consistently test at ≥99.9%, placing them in the ultra-high purity category suitable for the most demanding research applications.
What ≥99.9% Purity Means at Aminopeptides.ca
Our ≥99.9% HPLC purity standard is not a theoretical target — it is a tested, documented result for every lot we ship. Each batch is analyzed by an independent third-party laboratory before release. This applies across our entire catalogue, from semaglutide and tirzepatide to GHK-Cu and Epitalon.
We attach the CoA directly to your order, so you always have documentation for your lab records and institutional compliance requirements.
Tips for Evaluating Peptide Suppliers
- Ask for lot-specific CoAs — not generic documents. A real CoA references a specific lot number matching your vial.
- Look for third-party testing — in-house testing alone creates a conflict of interest. Independent laboratory verification is the standard.
- Check for MS confirmation — HPLC purity without mass-spec identity verification is incomplete. The dominant peak could be a co-eluting contaminant of similar polarity.
- Ask about net peptide content — a supplier who can tell you the NPC of their product is performing amino acid analysis, which indicates a higher level of quality control.
- Verify the supplier ships lyophilized product — pre-reconstituted peptides degrade faster and introduce contamination risk during transit.
- Confirm proper cold-chain handling — peptides should ship in conditions that maintain stability. Aminopeptides.ca ships from a Canadian facility with appropriate packaging.
Conclusion
Purity testing is the foundation of reliable peptide research. By understanding HPLC, mass spectrometry, amino acid analysis, and endotoxin testing, researchers can critically evaluate their suppliers and ensure their experimental results reflect the activity of the target compound — not contaminants. The distinction between gross weight and net peptide content is particularly important for researchers who need precise molar concentrations in their assays. At Aminopeptides.ca, third-party verified ≥99.9% HPLC purity is our baseline, not our ceiling.
Explore our full catalogue of research-grade peptides, all shipped from Canada with complete documentation.
Disclaimer
All products sold on Aminopeptides.ca are research-grade reference standards for laboratory research purposes only. Not for human consumption. Not a drug, not a cosmetic, not a dietary supplement.